Skip to Main Content

Author Details

Marie-H??l??ne Schlageter
Universite de Paris, U1 INSERM
1989
67
21
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34562020Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.Br J Haematol2022
35667096Prospective external validation of biomarkers to predict acute graft-versus-host disease severity.Blood Adv2022
32586907Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements.Haematologica2021
33767402Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups.Bone Marrow Transplant2021
33026828Analytical validation of eight methods of thyroglobulin measurement in fine-needle aspiration washouts.Ann Clin Biochem2021
31488557Synergistic effects of PRIMA-1<sup>Met</sup> (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemia.Haematologica2020
32826232The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.Cancer Discov2020
32614523Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patients.Int J Lab Hematol2020
32232827Paraneoplastic neutrophilic leukaemoid reaction in a patient with melanoma: association between tumour volume and leucocytosis.Br J Dermatol2020
32454215Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host Disease.Biol Blood Marrow Transplant2020
31413086Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.Haematologica2020
30259120Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls.Ann Hematol2019
28753865Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review.Eur Urol Focus2018
30023348Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European Experience.Eur Thyroid J2018
27983886Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.J Adolesc Young Adult Oncol2017
28377330Thyroglobulin assay in fluids from lymph node fine needle-aspiration washout: influence of pre-analytical conditions.Ann Biol Clin (Paris)2017
27728898Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.Int Immunopharmacol2016
25153604Evaluation of a new thyroglobulin sensitive assay in patients with differentiated thyroid cancer.Clin Chem Lab Med2015
26657197pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.Blood Cancer J2015
26486786Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.Blood2015
26378812DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.Oncotarget2015
26365596The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile.J Am Acad Dermatol2015
24201067Automated two-site immunofluorescent assay for the measurement of serum chromogranin A.Clin Biochem2014
25246112Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone.Reprod Biomed Online2014
22473461Coexistence of a myeloproliferative disorder and secondary polycythemia in the same patient.Am J Hematol2012
22996235Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.Clin Nucl Med2012
22448886Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.BMC Cancer2012
19167754When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).Leuk Res2009
19153070Therapy-resistant anaemia in congenital nephrotic syndrome of the Finnish type--implication of EPO, transferrin and transcobalamin losses.Nephrol Dial Transplant2009
18458957Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome.Pediatr Nephrol2008
18544082Auer rods and differentiation in acute promyelocytic leukemia.Br J Haematol2008
18503583Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.Br J Haematol2008
17426102Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.J Clin Endocrinol Metab2007
16728697Frequent antibody production against RARalpha in both APL mice and patients.Blood2006
15632209Farnesyltransferase inhibitor tipifarnib (R115777) preferentially inhibits in vitro autonomous erythropoiesis of polycythemia vera patient cells.Blood2005
16118343Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.J Clin Endocrinol Metab2005
15889256Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.Cancer Immunol Immunother2005
12819250Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.J Am Soc Nephrol2003
14566333PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.Nat Med2003
14551375Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.Nephrol Dial Transplant2003
14578760Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.Transplantation2003
12695164Primary Sjögren's syndrome associated agranulocytosis: a benign disorder?Ann Rheum Dis2003
11424001All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia.Hematol J2001
11299803Evaluation of total PSA assay on vitros ECi and correlation with Kryptor-PSA assay.Anticancer Res2001
11514400Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span.Clin Chem2001
11468229Intermethod discordance for alpha-fetoprotein measurements in Fanconi anemia.Clin Chem2001
10822223From guidelines to hospital practice: reducing inappropriate ordering of thyroid hormone and antibody tests.Eur J Endocrinol2000
10910897Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia.Blood2000
9732993Serum carcinoembryonic antigen, cancer antigen 125, cancer antigen 15-3, squamous cell carcinoma, and tumor-associated trypsin inhibitor concentrations during healthy pregnancy.Clin Chem1998
9168299Chronic myelomonocytic leukemia: from biology to therapy.Hematol Cell Ther1997
  • 1 - 50 of 67

Recommended Authors

Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 0
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Novartis Institutes for BioMedical Research
Career Start Year 1997
Number of shared co-authors 6
Clinical Immunology Lab, BC Children's Hospital
Career Start Year 1996
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1990
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1988
Number of shared co-authors 0
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 1
La Jolla Pharmaceutical Company
Career Start Year 1983
Number of shared co-authors 0
University of Leipzig
Career Start Year 1982
Number of shared co-authors 1
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 1
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 1
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 0
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
Child and Family Research Institute, University of British Columbia
Career Start Year 1979
Number of shared co-authors 0
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 1978
Number of shared co-authors 0
College of Agriculture and Life Sciences, Cornell University
Career Start Year 1977
Number of shared co-authors 0
University Hospital Munster
Career Start Year 1976
Number of shared co-authors 3
AUVA Trauma Hospital Salzburg
Career Start Year 1975
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1974
Number of shared co-authors 0
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Oslo University Hospital and Institute of Clinical Medicine, University of Oslo
Career Start Year 1973
Number of shared co-authors 1
National Heart Lung and Blood Institute Division of Intramural Research
Career Start Year 1972
Number of shared co-authors 1
The Johns Hopkins University School of Medicine
Career Start Year 1968
Number of shared co-authors 0
Sapienza University.
Career Start Year 1968
Number of shared co-authors 2
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 0
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1958
Number of shared co-authors 0

Collaborators

Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 5
Assistance Publique des Hopitaux de Paris (AP-HP)
Co-authored papers 4
Universite Paris Diderot
Co-authored papers 2
Universite de Strasbourg
Co-authored papers 2
Universite de Paris-Cite
Co-authored papers 2
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers 1
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 1
INSERM, France Villejuif Universite Paris-Saclay
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Universite de Paris, Inserm CIC 1427
Co-authored papers 1
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Duke University
Co-authored papers 1
University of Parma
Co-authored papers 1
Dana Farber Cancer Institute
Co-authored papers 1
Duke University School of Medicine Durham
Co-authored papers 1
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers 1
INSERM U1170, Universite Paris Saclay
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Hopital Universitaire Necker-Enfants Malades, Assistance Publique - Hopitaux de Paris
Co-authored papers 1
INSERM UMR , St Louis Hospital, University of Paris
Co-authored papers 1
Ben-Gurion University of the Negev
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Universite Nice Cote d'azur, CHU de Nice
Co-authored papers 1
Duke University
Co-authored papers 1